Sagimet Biosciences CEO David Happel's 2023 pay falls 59% to $2.7M
Sagimet Biosciences reports 2023 executive compensation
By ExecPay News
Published: April 18, 2024
Sagimet Biosciences reported fiscal year 2023 executive compensation information on April 18, 2024.
In 2023, four executives at Sagimet Biosciences received on average a compensation package of $1.5M, a 27% decrease compared to previous year.
Average pay of disclosed executives at Sagimet Biosciences
David Happel, Chief Executive Officer, received $2.7M in total, which decreased by 59% compared to 2022. 69% of Happel's compensation, or $1.8M, was in stock awards. Happel also received $330K in non-equity incentive plan, $503K in salary, as well as $3.6K in other compensation.
Eduardo Bruno Martins, Chief Medical Officer, received a compensation package of $1.5M, which increased by 181% compared to previous year. 39% of the compensation package, or $595K, was in option awards.
George Kemble, Chief Executive Officer, earned $930K in 2023, a 62% increase compared to previous year.
Dennis Hom, Chief Financial Officer, received $746K in 2023, which increases by 60% compared to 2022.
Related executives
You may also like
Source: SEC filing on April 18, 2024.